- Home
- Hepatology
- GLIMMER: A Randomized Phase 2b Dose-Ranging Trial of Linerixibat in Primary Biliary Cholangitis Patients With Pruritus

1w3 min read
Medical Article
Introduction Primary Biliary Cholangitis (PBC), a chronic autoimmune cholestatic liver disease, is characterized by progressive destruction of small intrahepatic bile ducts. A common and burdensome symptom in PBC is cholestatic pruritus (itch), affecting up to 74% of patients during the disease course and significantly impairing health-related qual

GLIMMER: A Randomized Phase 2b Dose-Ranging Trial of Linerixibat in Primary Biliary Cholangitis Patients With Pruritus
Similar Content

Postpartum Spontaneous Subcapsular Hepatic Hematoma
474 Reached5 Comments5 Likes

Woman with Persistent Lyme Disease
57 Reached

GCAP to improve Prognosis of Patients with Severe AH
490 Reached

Management of Autoimmune Pancreatitis
209 Reached2 Comments1 Likes

Woman with Complaint of Spontaneous Massive Rectal Prolapse
1865 Reached17 Comments9 Likes